Researchers characterized changes in the soft tissue sarcoma tumor immune microenvironment induced by standard neoadjuvant therapy with the goal of informing neoadjuvant immunotherapy trial design.
[Clinical Cancer Research]
7992332
{7992332:BBBBBBBB}
apa
50
1
171504
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/